Eli Lilly & Co. has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand Lilly's cancer treatment pipeline a few years before several patent expirations hit the drug maker
The scene looked like a flashback to ancient China.
A computer is as good as a second pair of eyes for helping a radiologist spot breast cancer on a mammogram, one of the largest and most rigorous tests of computer-aided detection found.
The actress tells Oprah about her delayed reaction to her cancer diagnosis and treatment decision
And a month after wedding, she still has to remember to say "wife" instead of "girlfriend"
An experimental menopause treatment that drugmaker Wyeth is developing reduced hot flashes, trouble sleeping and other symptoms and did not increase breast tenderness, a problem that bothers many women taking menopause drugs, according to data from two studies released Thursday.
Bringing a growing health concern to Congress, scientists squared off Thursday over whether cell phones contribute to brain cancer.
An experimental menopause treatment drugmaker Wyeth is developing reduced hot flashes, trouble sleeping and other symptoms
Researchers at the University of Pennsylvania have zeroed in on a possible marker for ovarian cancer. The discovery of the marker, called TEM1 and found in the blood vessels surrounding the tumor, could lead to new screening and treatment options.
Cancer patients will soon be able to use a medication patch to ease the debilitating nausea that often accompanies chemotherapy
Eli Lilly & Co. has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand Lilly's cancer treatment pipeline a few years before several patent expirations hit the drug maker
The scene looked like a flashback to ancient China.
A computer is as good as a second pair of eyes for helping a radiologist spot breast cancer on a mammogram, one of the largest and most rigorous tests of computer-aided detection found.
The actress tells Oprah about her delayed reaction to her cancer diagnosis and treatment decision
And a month after wedding, she still has to remember to say "wife" instead of "girlfriend"
An experimental menopause treatment that drugmaker Wyeth is developing reduced hot flashes, trouble sleeping and other symptoms and did not increase breast tenderness, a problem that bothers many women taking menopause drugs, according to data from two studies released Thursday.
Bringing a growing health concern to Congress, scientists squared off Thursday over whether cell phones contribute to brain cancer.
An experimental menopause treatment drugmaker Wyeth is developing reduced hot flashes, trouble sleeping and other symptoms
Researchers at the University of Pennsylvania have zeroed in on a possible marker for ovarian cancer. The discovery of the marker, called TEM1 and found in the blood vessels surrounding the tumor, could lead to new screening and treatment options.
Cancer patients will soon be able to use a medication patch to ease the debilitating nausea that often accompanies chemotherapy
Does a test that promises to find ovarian cancer sooner really do so? Could other tests nearing the market prolong survival by getting patients the right care faster?
The cervical cancer vaccine Gardasil also works to prevent cancers of the vagina and vulva, federal health officials said Friday, as they approved expanding its use to protect against those diseases as well
Every three minutes in the United States, a woman is diagnosed with breast cancer.
Scientists have mapped the cascade of genetic changes that turn normal cells in the brain and pancreas into two of the most lethal cancers
A radioactive tracer that "lights up" cancer hiding inside dense breasts showed promise in its first big test against mammograms, revealing more tumors and giving fewer false alarms
An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report
"I just wanted to kind of be rid of this whole thing for me," says the actress
As 3D images illuminate the viewfinder, a joystick delicately maneuvers a pair of robotic arms. It may sound like a video game, but Dr. Nikhil Shah is actually performing cancer surgery.
Doctors should stop routine prostate cancer screening of men over 75 because there is more evidence of harm than benefit, a federal task force advised Monday in a new blow to a much scrutinized medical test
What are you doing on your summer vacation? If you are an innovative student from the University of Southern California, the answer might be going to India, providing innovative water treatment measures to mitigate the spread of waterborne diseases, or educating locals on how to prevent oral cancer.
When I first heard about digital mammograms, my first thought was, "This could be good."
A new report questions their usefulness, finding that they don't save lives and may lead to twice as many unneeded biopsies
Both aggressive and hard to treat, liver cancer kills more than 650,000 a year worldwide. The American Cancer Society pegs the overall survival rate at less than 10%. Enter Aura Biosciences, a student startup that has developed an ingenious new means of delivering cancer-killing drugs to liver (and other) tumors.
A prostate cancer study that could change how doctors treat some patients found that widely used hormone-blocking drugs did not improve survival chances for older men whose disease hadn't spread
It was a long night, and Susan Niebur was feeling low. Normally, this working mom in Silver Spring, Maryland, can keep a shocking number of balls in the air and still smile. She's a physicist who works part-time as a consultant to NASA; an at-home mom to Matt, 1, and Andrew, 3; an animal-rescue volunteer; and a daily blogger. But Niebur, 35, is also a full-time cancer patient, and one night last fall her characteristic attitude of resolve and optimism failed her. After nearly six months of chemotherapy, the treatment's side effects -- which are cumulative -- were brutal.
A vaccine designed to prevent cervical cancer is coming under fresh scrutiny amid thousands of complaints linking it to a range of health problems.
Remember peeking through a View-Master? Scientists are using the same concept behind the classic kids' toy to try to see mammograms in 3-D
Merck's drug against HPV has been a boon to the company but is facing growing grass-roots opposition
Sen. Arlen Specter woke at 4 a.m. one day last week with an excruciating headache, a side effect of chemotherapy. Ninety minutes later, he was on the squash court, playing a partner less than half his age. That's the way Specter faces cancer and chemo. Borrowing a phrase from Winston Churchill, he calls it the "never-give-in" approach.
Cheryl Reed's morning routine starts like that of millions of other mothers around the country. She makes breakfast for her 8-year-old son and 6-year-old daughter, piles them into a minivan and drops them off at school.
Sen. Edward M. Kennedy checked out of a hospital Monday to return home to Massachusetts, a week after undergoing an aggressive and delicate surgery to treat a cancerous brain tumor, a hospital spokeswoman said
A team of doctors from the Mayo Clinic declared Friday that there appears to be no physical reason why Sen. John McCain, the 71-year-old presumed Republican presidential candidate, could not carry out the duties of the office.
One minute, Dr. Bernadine Healy was a perfectly healthy woman, in bed with her husband watching the Oscar De La Hoya fight on HBO. A few hours later, she was diagnosed with a malignant brain tumor.
Thomas Sedowski saw the big white dot on his brain scan, but thought he'd gotten a lucky break when the doctor called it a "lesion."
Sen. Edward Kennedy has the most common type of brain tumor, but the size and nature of the tumor will determine how life threatening it is, CNN's chief medical correspondent Dr. Sanjay Gupta said Tuesday.
The senator's seizure is diagnosed as a malignant tumor. But his chances of survival depend on exactly what type it is
His bout with melanoma after the 2000 campaign makes his health and his age election issues today. Why he's still at risk
Get your daughters off the couch: New research shows exercise during the teen years -- starting as young as age 12 -- can help protect girls from breast cancer when they're grown
Why do some smokers get cancer and others don't? Scientists have discovered two genetic variants that may be the reason
Daphne Babrow's son, Evan, is only 5 months old and she's already thinking about getting pregnant again. The decision won't be easy.
A recent green light from regulators could mean a brighter outlook from Genentech when the biotech meets with analysts Friday.
Gray goo or the future of medicine? CNN spoke to Naomi Halas, a professor at Rice University in Texas, about nanotechnology and her work on nanoshells, tiny particles that may hold the key to curing cancer.
Let's face it: There's no body part women obsess about more than breasts -- their size, shape, sag factor, and whether those strange pains stem from monthly PMS hormones or something more ominous, like breast cancer.
Nikki Caldwell's got 10 weeks to sell Pat Summitt on the sidecar.
U.S. cancer deaths rose by more than 5,000 in 2005, a somewhat disappointing reversal of a two-year downward trend, the American Cancer Society reported
Roy Scheider, a two-time Oscar nominee who played the alarmist police chief who famously saves a beach resort in the 1975 blockbuster Jaws and its sequel, died Sunday. He was 75.
A new report says your baby's bottle may leach a potentially toxic chemical. Should consumers do something about it?
Not every mother would allow her hair to be cut by her 4-year-old daughter, but Cindy Hurst thought it was a perfect idea.
With no work on Wisteria Lane these days (thanks to the Hollywood writers' strike), Desperate Housewives's Marcia Cross put her free time to use this week, lobbying Congress to pass 12-year-old legislation for breast cancer patients.
Scientists have traced a genetic mutation that causes a hereditary form of colon cancer back to a single couple who left England for America in the 1630s
Common genetic variants raise a man's risk of prostate cancer -- especially in combination with family history
Genentech, the word's largest biotech in terms of market capitalization, reported a healthy increase in sales and earnings for the fourth quarter.
Here is a list of the 61 cancer centers in the United States and links to their Web sites:
A new study shows that this once-popular breast-cancer therapy proves ineffective
So you're scared of breast cancer. Smart lady. Nearly 200,000 women will learn they have breast cancer this year, and you don't want to be one of them. You're doing everything you can to make sure you're not next -- doing breast exams, getting mammograms -- but you think it would be great if you could get a test to see if you'll develop breast cancer.
Genentech scientists won't waste any time fretting the FDA panel decision to reject Avastin as a breast cancer treatment. The reason: The biotech giant has at least three clinical breast cancer trials underway - at least one of which is likely to succeed.
A panel of FDA advisors did not support the use of Genentech's Avastin as a breast cancer drug.
Genentech Inc. faces a high-stakes decision by a government panel Wednesday over the cancer drug Avastin.
Cathy Bueti was widowed at the age of 25 when her husband was killed in a car accident. Seven years later, she says, "I finally started to feel like my life was coming back together, then I found the lump."
In discussions about breast cancer, the male form of the disease is often overlooked -- so, men end up going longer without diagnosis or treatment
New research shows the adage "what doesn't kill us makes us stronger" doesn't apply in treating breast cancer.
Actress Jaclyn Smith will never forget the day she found out she had breast cancer. And she'll never forget the lesson she learned in those very first moments of being a cancer patient.
Genentech reported a surge in third-quarter earnings that barely beat Wall Street projections, while its revenue increase fell just short of estimates.
A small California drug company hopes to extract the next cancer cure from Chinese herbs
Two studies show that chemotherapy doesn't work equally well for all cancers, raising hopes of tailoring the treatment
Which prostate cancer treatment is right for you? A new study suggests surgery may increase your chances of survival
We've heard for nearly a decade about the benefits of alcohol -- red wine in particular. It's good for your heart and may have other positive effects. In moderation, we thought, it's not only OK, but actually good for us.
Bristol-Myers Squibb faces a moment of truth this month when the FDA decides whether its experimental chemotherapy for breast cancer is good enough for the U.S. market.
Merck's cervical cancer vaccine Gardasil now faces direct competition from Glaxo's Cervarix, which was approved by European health authorities, said the vaccine's maker GlaxoSmithKline on Monday.
The American Cancer Society is devoting its entire $15 million advertising budget for 2007 to highlight the problems faced by Americans who don't have any or enough health insurance.
China has recalled two tainted leukemia drugs tied to "adverse reactions" in patients, the state-run Xinhua news agency reported Sunday.
ImClone stock fell Friday after an analyst downgraded the biotech, based on his conversation with doctors who were hesitant to use Erbitux as a lung cancer drug.
Edward Gramlich, a former member of the Federal Reserve board who raised warnings about the housing boom, died Wednesday of leukemia. He was 68.
Thousands more lung cancer patients each year could be offered surgery or other aggressive therapy under a new system that classifies many tumors as more treatable than in the past.
The FDA has approved the vaccine only for girls and women up to age 26. Now a medical debate is raging over whether older women should get it too
A large study from Europe suggests it doesn't hurt to wait a few years between prostate cancer screenings -- but the research won't end debate over the value of PSA tests.
Invasive breast cancer rates have fallen since the substantial decline in postmenopausal hormone replacement therapy occurred, even after a decline in breast cancer screening rates, according to findings published in the 5th Journal of the National Cancer Institute.
TThe drug helps protect teenage girls from the virus that can cause cervical cancer, but a new study shows it does little to help women who already are already infected
Eli Lilly & Co.'s osteoporosis drug Evista reduces the risk of breast cancer in some patients, but at a cost of an increased risk of serious side effects, regulatory reviewers said in documents released Friday.
Breast cancer survivors who ate more fruits and vegetables were not more likely to avoid a cancer recurrence
The FDA says no to labeling tomato products as anti-cancer foods. But that's no reason to cut the veggie from your diet
The French government has agreed to subsidize a cervical cancer vaccine made by Merck for teenage girls and young women, according to Merck's marketing partner, French drugmaker Sanofi-Aventis.
The market for blood cancer treatment is heating up. And that could result in a David versus Goliath face-off, or a potentially potent partnership.
GlaxoSmithKline announced the results of the biggest-ever study of a cancer vaccine Wednesday, in the hopes of bolstering the competitive strength of its Cervarix against Merck's Gardasil.
Pfizer Inc. said on Wednesday it has discontinued trials of an experimental lung cancer drug licensed from Coley Pharmaceutical Group after an independent review committee deemed it ineffective, spurring a 60 percent decline in Coley shares.
Health regulators granted priority review for Bristol-Myers Squibb Co.'s experimental breast cancer drug ixabepilone, and an approval decision on the medicine could come by late October, the company said on Tuesday.
What's scarier than mad cow disease? Nothing, really -- except illnesses that are 10 billion times more likely to hurt you. Think about it this way: Your risk of getting mad cow is much lower than your odds of winning the Powerball lottery. In short, it's not likely to happen. What could happen? In her lifetime, the average woman has a 1 in 2 chance of developing osteoporosis and a 1 in 3 chance of heart disease.
For the first time, doctors said Monday they have found a pill that improves survival for people with liver cancer, a notoriously hard to treat disease diagnosed in more than half a million people globally each year
Republican Sen. Craig Thomas of Wyoming, who had been battling leukemia since November, died Monday night at the National Naval Medical Center in Bethesda, Maryland, a family spokesperson told CNN. He was 74.
CEOs reveal the business strategies that put companies like Akamai, Netflix, and Priceline at the top of Business 2.0's ranking of the 100 fastest-growing technology companies.
It started with a pain behind the nipple. Within a few weeks, a lump started to grow. It got bigger and more painful until a doctor finally diagnosed stage 4 breast cancer. It's a story shared by thousands around the United States, only in this case, the patient's name is Bill Morley.
A genetic mutation that raises the risk of breast cancer is found in up to 60 percent of U.S. women, making it the first truly common breast cancer susceptibility gene, researchers report.
More than thirty years after President Nixon vowed to win the war on cancer, the battle rages on with no victor in sight. But that won't stop Big Pharma and biotechs alike from trying to entice investors next week with fresh reports on the hunt for a panacea.
The drugmakers Merck, Schering-Plough and Wyeth all reported strong first-quarter earnings - with Schering and Wyeth trouncing forecasts - but investor reaction was mixed.
Scientists have unlocked the genetic code that could pave the way to a new generation of highly effective cancer drugs with none of the painful side effects of existing treatments.
ImClone Systems Inc. said Tuesday that a late-stage trial of its cancer drug Erbitux failed to extend survival in patients with pancreatic cancer, sending its shares down more than 7.5 percent.
Stalled sales, failed drug experiments and an SEC inquiry are among the problems nagging at Amgen and Genentech as the world's two biggest biotech companies get set to report first-quarter earnings.
Dendreon's stock price surged immediately after the open of Friday trading, following an surprise positive vote from FDA advisors the day before, which favored the experimental prostate cancer treatment Provenge.
GlaxoSmithKline said it submitted an application for its cervical cancer vaccine Cervarix to the Food and Drug Administration, bringing it one step closer to challenging Merck's now-dominant Gardasil.
Provenge, an experimental prostate cancer treatment from the drug company Dendreon, could have a rough time winning over Food and Drug Administration advisors on Thursday, analysts say.
| Most Viewed | Most Emailed | Top Searches |
Video
Photos
